Nanobody-Based CTLA4 Inhibitors for Immune Checkpoint Blockade Therapy of Canine Cancer Patients

By
Justin.choi
-
0
101
The authors developed, characterized and assessed whether chimeric heavy chain only antibodies against CTLA4 were viable therapeutic candidates for the treatment of canine cancers.
[Scientific Reports]

Sorry, but the selected Zotpress account can't be found.

Full Article